Diag2Tec – Preclinical CRO in Multiple Myeloma, Lymphoma, Leukemia
  • Home
  • Our Expertise
    • Multiple Myeloma
    • Hematological Cancer Cell Lines from Patients
    • Primary Samples from Hematological Malignancies
    • In Vitro Model of Human Plasma Cell Differentiation
    • Flow Cytometry
    • NGS – Biomarkers – New Therapeutic Targets Identification
  • Preclinical Services
    • In vitro Drug Testing
    • Immunotherapies : Assays and Analyses
    • Prognosis and Predictive Biomarkers
  • About us
    • Team & History
    • Prospects and Partners
    • ISO 9001: 2015 Certification
  • Press & Events
    • List of Publications and Patents
    • Meet our team
  • Contact
    • Contact us
    • Opportunities
logo

Our News

Home → Our News

The publication’s team in the front cover of Theranostics journal

February 5, 2019 / News

Diag2Tec s’attaque au myélome multiple

November 14, 2018 / News

Diag2Tec présente son pitch aux investisseurs lors du salon Occitanie Invest

November 10, 2018 / News

BioPharlAnalyses

May 28, 2018 / News

Montpellier’s BIC

February 2, 2018 / News

2017 Annual Congress of American Society of Hematology

December 9, 2017 / News

Midi Libre Newspaper

June 28, 2017 / News

Diag2Tec lauréat du concours i-Lab

July 28, 2016 / News

i-Lab 2016 : Catégorie Création-développement

July 25, 2016 / News

Diag2Tec visit in Florida

May 23, 2016 / News

Interview of Jerome Moreaux, Diag2Tec’s CSO

November 4, 2015 / News

Diag2Tec soutenue par Crealia

June 18, 2015 / News

Jérôme Moreaux Lauréat Chercheur D’avenir 2013

February 5, 2013 / News

Diag2Tec’s Headquarters

Immeuble le Stratège
1095 rue Henri Becquerel
34000 Montpellier FRANCE

Diag2Tec’s Laboratories

CHU St Eloi, Dpt Hematology Biology
80 Av Augustin Fliche
34295 Montpellier FRANCE
Diag2Tec logo

  Contact us

Documentation

Services brochure
Publications and Patents
ISO 9001 Certification

Preclinical Services

In vitro Drug Testing
Immunotherapies : Assays and Analysis
Prognosis and Predictive Biomarkers
© Diag2Tec all rights reserved - Legal Notice
Back to Top